ALLOMAP ALLOMAP

Synonyms

Allscripts (AEHR) Order Name

Allomap

Sunrise Clinical Manager (SCM) Order Name

Allomap

EPIC Order Name

Allomap (CareDx)

Clinical Info

Requires coordination with CareDx and communication with the local laboratory prior to collection.
AlloMap Molecular Expression Testing (the AlloMap Test) is an In Vitro Diagnostic Multivariate Index Assay (IVDMIA) test service, performed in a single laboratory, assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells (PBMC). AlloMap Testing is intended to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection (ACR) at the time of testing in conjunction with standard clinical assessment.
The AlloMap Test is indicated for heart transplant recipients:
• 15 years of age or older
• At least 2 months (≥ 55 days) post-transplant

Specimen Type

Specimen Volume

Whole Blood collected in an 8mL BD STRECK Cell Free DNA BCT Tube with a minimum volume of 6mL.

Container

6.0-8.0mL WB in BD STRECK Cell Free DNA BCT Tube

Collection Instructions

Notify the laboratory prior to specimen collection.
Indicate collection time on the specimen.

Transport Instructions

Deliver immediately to the laboratory at ambient temperature. 

Specimen Stability

Stable at ambient temperature for a maximum of 3 hours (including laboratory processing time).

Methodology

AlloMap Molecular Expression - In Vitro Diagnostic Multivariate Index Assay

Days Performed

Tues, Wed, Thurs

Performing Laboratories

Natera Inc. 201 Industrial Rd Ste 410, San Carlos, CA 94070

CPT

PDM

235106

Result Interpretation

Forms